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The implantable cardioverter 
defibrillator
Implantable cardioverter defibrillator (ICD) 
therapy constitutes state-of-the-art and first-
line treatment for the prevention of sudden 
cardiac death (SCD) [1,2]. Key indications 
for ICD implantation are secondary preven-
tion in patients who have survived a previous 
cardiac arrest without transient or reversible 
cause or spontaneous symptomatic sustained 
ventricular arrhythmia and primary preven-
tion in patients who are considered at high 
risk due to a left ventricular ejection fraction 
≤35% with ischemic or nonischemic cardio-
myopathy in the absence of a history of cardiac 
arrest or sustained ventricular arrhythmia [3]. 
Risk reductions associated with ICD therapy 
compared with anti-arrhythmic drugs range 
from 37% for all-cause mortality to 57% for 
SCD, with ICDs being equally eff icacious 
as primary and secondary prevention [4].
Arrhythmias affect the electrical system of the 
heart, producing abnormal heart rhythms that 
cause the heart to pump less effectively. The ICD 
continuously monitors the heart rhythm, and 
will provide the appropriate therapy (i.e., either 
antitachycardia pacing [ATP], cardio version or 
a shock up to 800 V) to restore a normal rhythm 
if a life-threatening ventricular arrhythmia is 
detected. Generally, patients receive no warn-
ing prior to receiving a shock, and the shock 
itself may be uncomfortable and a disturbance 
to patients, who describe it as being similar to 
 getting kicked in the chest by a horse [5].
The number of patients with heart disease living 
with a cardiovascular implantable electronic 
device (CIED), such as the ICD, a biventricular 
pacemaker providing cardiac resynchronization 
therapy (CRT) or a biventricular pacemaker with 
an ICD (CRT-D), has increased substantially 
[6,7]. Currently, nearly 1 million patients in 
North America and more than 800,000 in 
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Implantable cardioverter defibrillator (ICD) therapy is the first-line treatment for the prevention 
of sudden cardiac death. Despite the demonstrated survival benefits of the ICD, predicting which 
patients will die from a ventricular tachyarrhythmia remains a major challenge. So far, psychological 
factors have not been considered as potential risk markers that might enhance the prediction 
of sudden cardiac death. This article evaluates the evidence for a link between psychological 
vulnerability, ventricular tachyarrhythmias and mortality and the pathways that might explain 
such a link. This review demonstrates that there is cumulative evidence supporting a link between 
psychological vulnerability and risk of ventricular tachyarrhythmias and mortality in ICD patients 
independent of disease severity and other biomedical risk factors. It may be premature to include 
psychological factors in risk algorithms, but information on the psychological profile of the patient 
may help to optimize the management and care of these patients in clinical practice.
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Europe have a CIED [8]. Since the approval by the US FDA and 
the first implantation in humans in 1980, the complexity of the 
ICDs has increased considerably with the introduction of novel 
features such as dual-chamber pacing and sensing, sophisticated 
algorithms to reduce the incidence of shocks and a 50-fold increase 
in device memory, while also reducing the size of the ICD (by 
a factor of 8) [9,10]. Hence, we are dealing with an increasing 
population of patients with an ICD with devices that are becoming 
increasingly complex, although more simple devices are now also 
being introduced, such as the entirely subcutaneous ICD system 
(S-ICD®; Cameron Health Inc., CA, USA), which is implanted 
without leads in or on the heart, thereby preserving the vasculature 
of the heart [11].
Risk stratification: an unresolved challenge
Despite the demonstrated benefits of ICD therapy, predicting 
which patients will die suddenly from a ventricular arrhyth-
mia remains a major challenge in clinical cardiology practice. 
Left ventricular dysfunction has been used for risk stratifica-
tion but appears to lack sufficient sensitivity and specificity 
to be a good predictor of risk for SCD [12]. Other potential 
candidates have been pursued, such as markers of autonomic 
nervous system functioning (e.g., heart rate variability and 
baroreflex sensitivity) and microvolt T-wave alternans, but as 
single markers, they seem to fall short of resolving the issue 
of optimal risk stratification [12]. Studies examining the con-
tribution of multiple risk markers, such as the ABCD and the 
REFINE-ICD efficacy trials, show more promising results in 
terms of being closer to obtaining better prediction models 
[13,14]. The challenge of generating algorithms that are suf-
ficiently sensitive and specific to predict which patients are at 
risk of SCD is probably attributable to the complex patho logy 
 underlying SCD and the contribution of several different pro-
cesses and factors interacting, including  markers of arrhythmic 
and  nonarrhythmic death [12].
Risk stratification: is there a role for psychological 
factors?
The pursuit of factors that may help to enhance risk stratifica-
tion has mainly focused on clinical factors and physiological 
markers, negating the potential role of psychological factors. At 
this point in time, it may be too premature to suggest the inclu-
sion of psychological factors in risk algorithms. Nevertheless, 
there is evidence to suggest that traumatic and psychologically 
taxing life events, as shown in studies examining the impact of 
the terrorist attack on the World Trade Center on 9/11, may 
increase the risk of shocks in ICD patients with a relative risk 
of more than twofold [15,16]. Although such events are rare, psy-
chological distress and morbidity are not uncommon in ICD 
patients with prevalence rates of approximately 20–25% for 
anxiety and depression, as reported in a recent meta-analysis 
[17]. Post-traumatic stress disorder (PTSD) is also seen in ICD 
patients, although the prevalence is somewhat lower, ranging 
from 7–11% [18,19]. Chronic levels of distress seem to be high in 
the subset of patients who are already anxious at the time of ICD 
implant, with as many as 50% of patients remaining anxious for 
12 months postimplantation [20].
Whether distress in ICD patients should be attributed to the 
device itself, associated therapies such as appropriate and inap-
propriate shocks [21], hardware malfunctioning [22], underlying 
disease (e.g., symptomatic heart failure) [23,24], indication for ICD 
implantation [25], or the patient’s preimplant psychological func-
tioning [26] and personality disposition [27] is the subject of some 
debate. Irrespectively, if one out of four ICD patients suffers from 
significant levels of distress, there is a need to know whether this 
has consequences above and beyond its impact on quality of life 
[28] in this vulnerable subset of patients.
Hence, the aim of this review is to examine the evidence for 
a link between psychological vulnerability, ventricular tachy-
arrhythmias and mortality in ICD patients and to discuss 
the mecha nisms that may be responsible for this link and the 
implications for future research and clinical practice.
Evidence for a link between psychological vulnerability 
& poor clinical outcome
To date, 15 individual studies have examined the association 
between psychological vulnerability and distress and ventricu-
lar tachyarrhythmias and mortality in ICD patients. Out of all 
studies, seven focused on ventricular tachyarrhythmias as the 
outcome, while six studies focused on mortality and two on both. 
Table 1 provides an overview of these studies, with the main results 
summarized in the following section.
Ventricular tachyarrhythmias
In 1999, Dunbar et al. were the first to examine the emotional 
status of the patient as a potential determinant of arrhythmias 
in ICD patients. A higher level of total mood disturbance, as 
assessed using the Profile of Mood States, was associated with a 
greater likelihood of experiencing an arrhythmia that required 
ATP, cardioversion or shock [29]. For each 10-point increase on 
the Profile of Mood States, the chance of experiencing an arrhyth-
mia increased by 10–20%, after controlling for factors that are 
traditionally associated with arrhythmia risk. More specifically, 
higher anxiety, fatigue or confusion levels and a lower vigor level 
at 1- and 3-month postimplantation were associated with a higher 
risk of arrhythmia at 3 and 6 months, respectively. Neither anger 
nor depression was a significant predictor. Baseline level of mood 
disturbance before ICD implant did not predict occurrence of 
arrhythmic events at 1- or 3-month follow-up. In 2005, Whang 
et al. showed that moderate-to-severe depression (Center for 
Epidemiologic Studies Depression [CES-D] Scale ≥27) was asso-
ciated with a statistically significant increased risk of appropriate 
ICD shocks, after controlling for multiple potential confounders 
[30]. However, three other studies in ICD recipients did not sup-
port an association between patient-reported health status [31], 
patient-reported [32] or physician-diagnosed [33] depression or anxi-
ety and ventricular tachyarrhythmias. In two of these studies, the 
association between psychological distress and the occurrence of 
ICD shocks has approached statistical significance in univariate 
analysis (p = 0.09) [32,33].
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Three studies examined the link between psychological distress 
and ventricular arrhythmias in ICD patients that had already 
received one or more shocks. Using structured interviews, Fries 
et al. asked patients who had received an appropriate shock to 
indicate the presence and intensity of negative emotions (i.e., 
tension/nervousness, depression or anger) during 1 h before a 
recurrent shock [34]. Based on the responses, the calculated rela-
tive risk of arrhythmia recurrence associated with mental stress 
was 9.5 (95% CI: 6.3–14.5). In another study, 42 ICD patients 
were asked to complete a diary page when they experienced a 
shock to retrospectively evaluate their mood state in the 15 min 
preceding the shock [35]. Results showed that moderate levels 
of anger were more likely during the period preceding shock 
than during a matched control period 1 week later. Other mood 
states (i.e., anxiety, worry, sadness, happiness, challenge, feeling 
in control or interest) did not differ prior to shock compared 
with the control period. In 2004, Burg et al. showed that the 
patients in this sample who reported at least moderate anger 
in the 15 min preceding shocks scored significantly higher on 
trait anger than those who did not (p < 0.0001) [36]. Trait anger 
was independently associated with anger-triggered arrhythmias 
(p < 0.0001). In addition, patients who reported at least moderate 
anxiety before shock scored significantly higher on trait anxiety 
(p < 0.008). Van den Broek et al. showed that the clustering of 
anxiety at the time of implant and having a distressed (Type D) 
personality predicted arrhythmia, while no main effect was found 
for anxiety or depression [37]. Patients with a Type D personal-
ity experience a broad range of negative emotions and tend to 
inhibit self-expression in social interaction [38]. The two latter 
studies suggest that stable psychological factors increase the risk 
of emotion-triggered appropriate shocks in ICD patients.
In aggregate, there is some evidence that psychological distress 
may increase the risk for ventricular arrhythmias in ICD patients 
but negative studies are also available. These mixed findings might 
be attributed to differences in study design, the measure(s) used 
to assess psychological distress, sample size and variability in the 
follow-up period. In addition, stable psychological factors (e.g., 
personality) may modulate the influence of emotional distress on 
arrhythmias [36,37].
Mortality
In the past 5 years, studies that examine the impact of psycho-
logical vulnerability and distress on mortality in ICD patients 
have emerged. A substudy of the prospective AVID trial showed 
that a disease- specific quality of life measurement (Quality of Life 
Index – Cardiac Version [QLI-CV]) was a significant predictor of 
all-cause mortality, even after controlling for conventional clinical 
risk factors, including left ventricular function and symptomatic 
heart failure [39,40]. However, the mental health component score 
of the generic 36-item Short Form Health Survey (SF-36) was 
not associated with mortality. By contrast, the MADIT-II trial 
showed a significant association between mental health status, as 
assessed with the SF-12, and mortality [31]. In adjusted analyses, 
patients who reported psychological distress had a 39% higher 
risk of mortality.
Ladwig et al. showed that patients reporting symptoms of 
PTSD after ICD implantation had a threefold higher mortality 
risk, even after adjusting for ICD-specific factors and for affective 
morbidity [41]. In another study, the risk of poor prognosis was 
enhanced by twofold in patients with a Type D personality or 
patients with a high preimplantation level of ICD concerns (i.e., 
patient concerns about the ICD giving a shock, and irrespective 
of whether patients have actually received a shock) [42]. The risk of 
poor prognosis increased to almost fourfold in patients with clus-
tering of both psychological risk markers compared with patients 
with only one or none of these markers [42].
In a recent cohort study with a long-term follow-up, the pres-
ence of depressive symptoms was shown to significantly increase 
the risk for all-cause mortality in ICD patients [43]. However, 
depression lost its predictive value when adjusting statistically 
for potential confounders [43]. The association between depres-
sion and mortality was investigated further by van den Broek 
et al., with depression also being subdivided into two symptom 
dimensions (i.e., somatic symptoms and cognitive symptoms) [44]. 
Results indicated that somatic, but not cognitive, symptoms of 
depression predicted mortality, independent of demographic and 
clinical factors. Patient-reported negative, but not positive, mood 
was also independently related to all-cause as well as cardiac-
related mortality [44]. In a recent study in patients with a CRT-D, 
Shalaby et al. found that patients with a diagnosed mood disorder 
were at a significantly higher risk of heart failure hospitalization 
or combined heart failure hospitalization and mortality, but not 
mortality alone [33].
Thus, the majority of available studies support an association 
between psychological distress and mortality in ICD patients, 
indicating that a subset of patients is at risk of mortality despite 
state-of-the-art treatment due to their psychological profile. 
Whether psychological factors exert an independent effect on 
clinical outcome in ICD patients or whether their relationship 
with clinical outcome can be explained by other factors that are 
causally related to this outcome is so far unclear.
Mechanisms linking distress to poor health outcomes
There are several plausible mechanisms that may explain the 
association between psychological distress and ventricular tachy-
arrhythmias and mortality in ICD patients. However, most of 
this evidence is implicit and is derived from studies that were 
conducted in individuals without somatic disease or in patients 
with general cardiovascular disease. These pathophysiological and 
behavioral mechanisms will be outlined in further detail below.
Autonomic nervous system dysfunction
An imbalance between the sympathetic and parasympathetic nerv-
ous systems is assumed to be one of the primary physiological 
mechanisms through which distress may influence overall health 
and predict clinical outcomes in patients with cardiovascular 
disease [45]. Patients with depression and anxiety tend to have 
impaired vagally mediated baroflex control of the heart and an 
increase in sympathetic tone, characterized by an increased level 
of norepinephrine [46], a decrease in heart rate variability [47,48] 
Pedersen, Brouwers & Versteeg
383www.expert-reviews.com
Review
and abnormal heart rate turbulence [49]. These parameters that 
reflect imbalance in autonomic tone have been implicated in the 
onset of cardiac events, including ventricular fibrillation, ventricu-
lar arrhythmias and mortality in ICD patients [35,43,50], and in 
patients  postmyocardial i nfarction [49,51].
Heterogeneities in ventricular repolarization:  
QT-dispersion & T-wave alternans
Heterogeneities in ventricular repolarization, including 
QT-dispersion and T-wave alternans, have also been implicated 
in cardiovascular prognosis and SCD [45]. The QT-interval is the 
electrocardiographic representation of ventricular repolarization 
time, and variability in the QT-interval has been consistently linked 
with depression and emotional stress in patients with a myocardial 
infarction or acute coronary syndrome [52,53]. These findings could 
be explained by the use of selective serotonin reuptake inhibitors 
(SSRIs) and tricyclic antidepressants, which are known to exert a 
proarrhythmic effect attributed to cardiac and vascular sodium, 
potassium and calcium channel blockage and disruption of chan-
nel protein trafficking [54], thereby causing a prolongation of the 
QT-interval. However, findings on this topic are scarce, and in 
only one of the studies, the relation between QT-interval and 
depression remained significant even after excluding patients on 
 antidepressants, but only among women [52].
T-wave alternans is a marker of ventricular repolarization insta-
bility that may be mechanistically related to arrhythmias [55]. One 
study found that T-wave alternans induced by anger in a labora-
tory setting predicted future ventricular arrhythmias in patients 
with an ICD, suggesting that distress (e.g., anger) may lead to 
repolarization instability [56].
Inflammation
Depression might lead to an increased activity of the hypothalamic –
pituitary–adrenal axis, which results in corticotrophin hyper-
secretion, increased release of glucocorticoids and elevated 
corticotrophin-releasing hormone activation [57]. Cortisol, which 
is the primary glucocorticoid in humans, and corticotrophin-
releasing hormone have been found to stimulate proinflammatory 
cytokine release, which exerts a deleterious effect on the heart 
due to its implication in plaque ruptures [58] and by suppressing 
cardiac contractility [58] while impeding cardiac remodeling [57,59]. 
In addition, excess cortisol can contribute to abdominal obesity, 
insulin resistance, hypertension, oxidative stress, altered plasma 
lipoprotein metabolism and vascular tone change, which can all 
contribute to cardiovascular disease progression [45].
Two studies found elevated levels of anxiety and PTSD to be 
independently associated with abnormal levels of acute-phase 
proteins and several proinflammatory cytokines (e.g., IL-6 and 
TNF-α in cardiac patients) [60]. In addition, Type D personality 
was associated with higher levels of proinflammatory cytokines 
and lower levels of anti-inflammatory cytokines in patients with 
heart failure [61].
Up until now, a paucity of studies have investigated the relation-
ship between inflammatory (bio)markers and ventricular tachy-
arrhythmias in ICD patients. One study found no correlation 
between plasma levels of IL-6, TNF-α, high-sensitive C-reactive 
protein and brain natriuretic peptide and ventricular arrhythmic 
events among stable heart failure patients having ICDs, while in 
another study, high-sensitive C-reactive protein was correlated 
with ventricular tachyarrhythmias in 121 ICD recipients over a 
1-year period [62,63].
Platelet activation
A few studies have found a link between depression and change 
in platelet activation [68], and between phobic anxiety and abnor-
malities in the platelet serotonin transporters and intracellular 
calcium levels, leading to changes in the fibrinolytic system [64]. 
Platelets play a key role in the development of atherosclerosis, 
thrombosis and acute coronary syndromes [65], thereby possibly 
increasing the risk for cardiac mortality in ICD patients. This 
effect might be attenuated by the use of SSRIs, since these have 
been demonstrated to reduce platelet activation by inhibiting their 
serotonin uptake capacity that is necessary for platelet aggrega-
tion. SSRIs may, therefore, also protect against the risk for new 
cardio vascular events [66]. However, it is not completely clear 
whether the normalization of platelet function after SSRI treat-
ment is the result of a decrease in depressive symptoms or due to 
a direct effect on the platelets [67].
Behavioral mechanisms
On the behavioral side, the primary candidate mechanisms 
that could explain poor health outcomes in distressed ICD 
patients include poor medication adherence, insufficient exer-
cise, unhealthy lifestyle habits and the cancelling of scheduled 
medical appointments [68,69]. Evidence suggests that patients with 
depression also tend to forget or skip their medication more often 
after adjustment for potential confounding variables, including 
age, ethnicity, education, social support and measures of cardiac 
disease severity [69], thereby increasing the risk of arrhythmias and 
mortality. Similarly, depression has found to be a strong deter-
minant of all dimensions of subjective fatigue in patients with 
coronary artery disease [70], which may influence patient motiva-
tion to engage in exercise [70]. The lack of exercise may also result 
from anticipatory anxiety, with ICD patients having a restricted 
lifestyle because of the fear of a shock [71]. In addition, PTSD has 
been associated with a higher rate of physical inactivity in terms 
of overall exercise and self-rated level of exercise in cardiovascular 
patients [72]. Owing to inactivity, distressed patients may experi-
ence weight gain and be more prone to develop obesity. Weight 
gain and obesity can also be side effects of psychotropic drugs 
prescribed for affective disorders [73]. Depressed patients who have 
been hospitalized for cardiovascular disease are also more likely 
to smoke [74], with smoking probably serving as an ‘emotional 
painkiller’. Smoking is known to cause a restriction of the arter-
ies, modify oxygen-dependent enzymes, increase blood pressure, 
diminish the amount of oxygen in the body and reduce blood 
flow to the extremities [75]. Chemicals present in cigarettes lead 
to atherosclerosis and damage arteries and blood vessels, which 
eventually lead to cardiovascular disease, arrhythmogenic events 
or death [75].
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Furthermore, impaired cognitive focus, reduced energy and 
motivation associated with depression and anxiety might affect 
patients’ willingness to engage in self-care, to attend scheduled 
hospital appointments and to complete cardiac rehabilitation 
[76,77]. In addition, Type D personality has been associated with 
inadequate consultation behavior among heart failure patients 
(i.e., consulting a physician when experiencing cardiac symp-
toms), increasing the risk for adverse clinical outcomes in patients 
with this particular personality profile [78].
Conclusion
Cumulative evidence from large-scale prospective studies indicates 
that distress and psychological vulnerability may increase the risk 
of ventricular tachyarrhythmias and mortality in ICD patients, 
independent of traditional clinical risk factors and despite state-of-
the-art treatment with this life-saving device. Further research is 
warranted to disentangle whether psychological factors constitute 
risk factors in their own right, whether they exert indirect effects 
via physiological and behavioral pathways, or whether their link 
with prognosis can be explained by other factors. Although it may 
be too premature to suggest the inclusion of psychological factors 
in risk algorithms, information on the psychological profile of the 
patient may help to optimize the management and care of this 
subset of vulnerable ICD patients in clinical practice.
Expert commentary
There is considerable evidence that patients implanted with an 
ICD may be at increased risk for ventricular tachyarrhythmias 
and mortality due to their preimplant psychological vulnerability 
or postimplant distress level, as shown in this review. The major-
ity of this evidence comes from large-scale and well-designed 
prospective studies, emphasizing that the evidence is unlikely 
to be spurious. Moreover, the risk associated with psychological 
vulnerability and distress is clinically relevant, with up to a three-
fold increased risk, and seems to be independent of traditional 
risk factors, such as left ventricular dysfunction and extent of 
heart failure as indicated by New York Heart Association func-
tional class [31,37,41]. Thus, despite state-of-the-art treatment with 
ICD therapy for the prevention of SCD, a subset of patients die 
prematurely due to their psychological profile and do not ben-
efit optimally from their device. This should be placed in the 
context of the cost of the ICD, which is considerable, with an 
average price of US$25,000 for the device itself [79]. Although 
cost–effectiveness analyses of ICD treatment as compared with 
antiarrhythmic drugs showed that device therapy is cost effective 
[80,81], these studies did not take into account the psychological 
risk profile of patients.
Further research in this area is warranted in order to estab-
lish whether psychological factors carry independent risk, act 
indirectly via physiological or behavioral pathways, or whether 
they can be explained by other factors. We should also explore 
whether psychological factors interact with demographic and 
clinical risk factors to enhance risk for poor clinical outcome 
and whether psychological factors have a place in algorithms used 
for risk stratification. With this knowledge, we will be better able 
to manage and care for the subset of ICD patients who have an 
increased vulnerability for adverse clinical outcomes due to their 
psychological profile. Until such evidence is available, we need 
to accept that the psychological profile of ICD patients matters 
in the clinical management and care and that a vicious cycle may 
ensue if we do not target distress in our patients irrespective of the 
cause (i.e., ICD shock, underlying heart disease, preimplantation 
psychological profile, and so on) of that distress (Figure 1) [82]. Such 
investment seems worthwhile given the cost of the ICD but also 
for the sake of the well being of our patients, as it would otherwise 
be tantamount to ignoring the considerable body of evidence from 
cardiovascular and behavioral medicine that shows that the body, 
mind and heart interact to influence health outcomes in cardiac 
patients [83].
Five-year view
Over the course of the next 5 years, if we continue to invest in 
the patient perspective in patients with an ICD combined with 
evaluating potential mechanistic pathways, we will be able to docu-
ment the role of the patient’s psychological profile and level of 
postimplant distress on clinical outcome and identify the subset of 
patients at the greatest risk for SCD. We will be more knowledge-
able about the factors that determine the risk for SCD, whether 
it be due to the complex pathology underlying SCD, the psycho-
logical profile of the patient, or an interaction between several 
different processes and factors of a physiological, behavioral and 
psycho logical nature. Currently, there is considerable interest in the 
patient perspective by policy-makers, physicians and other health-
care professionals. This is also reflected in the recommendations 
as set out by the American Institute of Medicine for the healthcare 
















Figure 1. Supposed vicious cycle of shocks and distress. 
HR: Heart rate; HRV: Heart rate variability.  
Adapted from [82] with permission from Oxford University Press.
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consistent and high-quality care that is patient-centered [84]. In 
these recommendations, it is stipulated that future medical treat-
ment should fulfil the key aspects of being safe, effective, timely, 
equitable, efficient and patient-centered. The European Heart 
Rhythm Association – under the auspices of the European Society 
of Cardiology – also emphasizes the importance of the patient 
perspective in their mission statement: “The European Heart 
Rhythm Association mission statement is to improve the quality-
of-life of the European population by reducing the impact of car-
diac arrhythmias and reduce sudden cardiac death.” Similarly, the 
device industry is investing in the patient perspective by including 
quality of life as an end point when designing trials and registries 
to evaluate the safety and efficacy of new hardware and algorithms 
(e.g., to reduce appropriate and inappropriate shocks).
This holds an important promise for the future wellbeing of 
ICD patients and is hopefully a trend that will continue. Based 
on these trends, it will be interesting to see how the manage-
ment and clinical care of ICD patients will evolve during the 
next 5 years also due to changes in clinical care, with more ICD 
patients being followed via remote monitoring. One of the impor-
tant questions will be whether the subset of ICD patients with 
a vulnerable pre-implant psychological profile or postimplant 
distress will be detected and treated in order to preserve their 
wellbeing and enhance their survival. Screening and monitor-
ing of ICD patients for mental health issues is not yet part of 
standard clinical practice, but will hopefully be entered on equal 
footing with offering patients cardiac rehabilitation in the future. 
Current evidence from behavioral and psychological intervention 
trials in ICD patients indicates that we have something to offer to 
the subset of vulnerable ICD patients in terms of reducing their 
distress levels and improving their wellbeing. Even though some 
of these trials are plagued by methodological short comings, they 
show that multifactorial interventions are likely to be the most 
successful, including for example cognitive behavioral therapy, 
psycho-education about the ICD and cardiac rehabilitation as 
some of the mainstay components [85], which can, if warranted, 
be combined with pharmacological treatment. Other trials with 
the aim to improve mental health outcomes in ICD patients are 
currently underway that use comprehensive and state-of-the-art 
techniques in behavioral medicine, including e-health [86,87].
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Key issues
• Implantable cardioverter defibrillator (ICD) therapy is the first-line treatment for the primary and secondary prevention of sudden 
cardiac death, with superior survival benefits compared with antiarrhythmic drugs.
• Predicting which patients who will die suddenly from a ventricular tachyarrhythmia still remains a major challenge in clinical cardiology 
practice.
• The pursuit of factors that may help to enhance risk stratification has solely focused on clinical and physiological factors, despite 
cumulative evidence supporting a link between psychological vulnerability and the risk of ventricular tachyarrhythmias and mortality in 
ICD patients.
• Little is known about the pathways through which psychological factors may exert an influence on clinical outcome in ICD patients, 
with both plausible physiological and behavioral pathways existing.
• Further research is warranted to establish whether psychological factors comprise risk factors or risk markers that may be attributed to 
other factors, such as an imbalance between the sympathetic and parasympathetic nervous systems.
• It may be premature to include psychological factors in risk algorithms, but information on the psychological profile of the patient may 
help to optimize the management and care of this subset of vulnerable ICD patients in clinical practice.
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